Creative Biolabs offers the unique native chicken IgY antibody production service by our proprietary Native™ Antibody Discovery Platform. This platform can produce extraordinarily high specificity and affinity native antibodies to be used for biomedical research and antibody manufacturing.
In the antibody research, chicken is considered an ideal host for generating antibodies against mammalian or human protein antigens. Since chickens are at least 100 million years removed from mammals, they tend to recognize any mammalian gene product as foreign, and mount vigorous immune responses. In addition, a faster antibody response can occur in chicken hosts compared to in mammalian species. Moreover, the process of producing chicken antibodies is also much easier compared to other host species, as the specific antibodies are generally isolated from the egg yolk.
The distinct advantages for using chickens produce antibodies are including:
Creative Biolabs has developed a powerful Native™ Antibody Discovery Platform to generate high quality custom native IgY antibodies. This platform is based on antigen-specific B lymphocytes flow cytometry technology, which can isolate antigen-specific B cells from bone marrow cells, lymph node cells or peripheral blood cells of immunized chicken by FACS. Through this exclusive platform, a larger number of candidate antibodies, with native paired heavy- and light-chains, can be discovered. Native™ is undoubtedly by far the most efficient way in developing chicken antibodies.
Creative Biolabs is a global leading provider for custom antibody production services. Our experienced scientists can offer services for all needs in the entire antibody production procedure, including peptide synthesis, conjugation, antibody production and purification. We are confident in generating high quality native chicken IgY antibodies to facilitate the customers’ research project.
All listed customized services & products are for research use only, not intended for pharmaceutical, diagnostic, therapeutic or any in vivo human use.